Correlation Between Dianthus Therapeutics and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dianthus Therapeutics and Caribou Biosciences, you can compare the effects of market volatilities on Dianthus Therapeutics and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Caribou Biosciences.
Diversification Opportunities for Dianthus Therapeutics and Caribou Biosciences
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dianthus and Caribou is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Caribou Biosciences go up and down completely randomly.
Pair Corralation between Dianthus Therapeutics and Caribou Biosciences
Given the investment horizon of 90 days Dianthus Therapeutics is expected to generate 1.54 times more return on investment than Caribou Biosciences. However, Dianthus Therapeutics is 1.54 times more volatile than Caribou Biosciences. It trades about -0.03 of its potential returns per unit of risk. Caribou Biosciences is currently generating about -0.34 per unit of risk. If you would invest 2,320 in Dianthus Therapeutics on November 2, 2024 and sell it today you would lose (143.00) from holding Dianthus Therapeutics or give up 6.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dianthus Therapeutics vs. Caribou Biosciences
Performance |
| Timeline |
| Dianthus Therapeutics |
| Caribou Biosciences |
Dianthus Therapeutics and Caribou Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dianthus Therapeutics and Caribou Biosciences
The main advantage of trading using opposite Dianthus Therapeutics and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.| Dianthus Therapeutics vs. Lion One Metals | Dianthus Therapeutics vs. Nicola Mining | Dianthus Therapeutics vs. Sphere Entertainment Co | Dianthus Therapeutics vs. Zijin Mining Group |
| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |